Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study-Reference-Cited by-同舟云学术

Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study

Published:2018-07 Issue:7 Volume:19 Page:880-888
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Murthy Rashmi,Borges Virginia F,Conlin Alison,Chaves Jorge,Chamberlain Marc,Gray Todd,Vo Alex,Hamilton Erika

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. SEER cancer statistics review, 1975–2012;Howlader,2015

2. United States cancer statistics: 1999–2009 incidence and mortality web-based report,2013

3. HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues;Owens;Clin Breast Cancer,2004

4. Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline;Giordano;J Clin Oncol,2014

5. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of trastuzumab and its efficacy and safety in HER2-positive cancer patients;Cancer Chemotherapy and Pharmacology;2024-08-23

2. Recent advances in breast cancer metastasis with special emphasis on metastasis to the brain;Pathology - Research and Practice;2024-08

3. Discovery of Potent and Selective Covalent Inhibitors of HER2^WT and HER2^YVMA;Journal of Medicinal Chemistry;2024-05-31

4. Trans-activating mutations of the pseudokinase ERBB3;Oncogene;2024-05-28

5. HER3 V104 mutations regulate cell signaling, growth, and drug sensitivity in cancer;Molecular Carcinogenesis;2024-05-15